Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 20,000 shares at $8.00 ($160K) on 2016-08-22, disclosed to the SEC on 2016-08-26.
Open-market sale of $160k ARWR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 13,100 | $105K | 65.5% |
| 2 | $8.00 | 6,900 | $55K | 34.5% |
| Total | $8.00 avg | 20,000 | $160K | 100% |
| Filing → |
| ARWR | SELL | 2024-01-08 | $885K | — | Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |